| Name | HDAC-IN-38 |
|---|
| Description | HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5)[1]. |
|---|---|
| Related Catalog | |
| Target |
HDAC8:0.533 μM (IC50) HDAC6:1.27 μM (IC50) HDAC3:2.86 μM (IC50) HDAC1:3.82 μM (IC50) HDAC5:6.27 μM (IC50) HDAC2:6.62 μM (IC50) |
| References |
| Molecular Formula | C27H28ClN3O2 |
|---|---|
| Molecular Weight | 461.98 |